vVARDIS has secured a strategic investment from Apollo-managed funds, achieving a valuation over $1 billion. The funding will support expansion across the U.S. and Europe.
Round Type
Corporate Round
ZugManufacturingBiotechnologyHealth CareInvestors
Description
Swiss dental medtech vVARDIS received a minority investment from Apollo-managed funds, surpassing a $1 billion valuation. The funding will help support continued expansion across the U.S. and Europe. Founded in 2019, vVARDIS develops innovative dental treatments
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as vVARDIS that raised within 45 days of this round, from Fundz verified event records.
- NVENTRIC raised $23M on June 10, 2026.
- FesariusTherapeutics raised $20M (Series A) on June 10, 2026.
- Nanordica Medical raised $1.8M (Seed) on June 10, 2026.
- Flyte Aviation, Inc. raised $1M (Post-IPO Equity) on June 7, 2026.
- Advanced NanoTherapies raised $31M (Series B) on June 2, 2026.
- Veritas Aortic Solutions raised $12M (Seed) on June 1, 2026.
Who to call at vVARDIS, and when
A new round usually means vVARDIS is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day vVARDIS raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at vVARDIS, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at vVARDIS. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment vVARDIS raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
vVARDIS raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.